Español
English
Français
Deutsch
РусскийSEGO updates cervical cancer screening protocol: key points of the new 2025 consensus
The Spanish Society of Gynaecology and Obstetrics has published its revised national screening protocol, introducing HPV testing as the primary test from age 25 and redefining follow-up intervals by risk group.
Latest clinical news
AI for oncology: a 2026 system aims to keep clinical answers aligned with changing evidence
SentryLine explores how to detect changes in living clinical guidelines and provide traceable, time-aware answers.
AI in obstetrics and gynaecology faces a key challenge: using longitudinal clinical evidence reliably
A new 2026 benchmark shows that models can lose accuracy when they must extract evidence from complex longitudinal clinical records.
ESHRE 2026 highlights endocrine-disrupting exposures and fertility
Reproductive medicine is increasingly studying how environmental exposures may interact with the oocyte environment.
Recipient age still influences outcomes even with donor eggs
Data presented at ESHRE 2026 suggest that reproductive ageing is not completely neutralised by donor eggs.
AI for blastocyst analysis: one model combines segmentation, grading and implantation prediction
A 2026 study presents an explainable model that analyses several blastocyst features within one system.
MRI radiomics explores new ways to characterise endometriosis
A 2026 study examines whether quantitative MRI features can help subtype endometriosis, while highlighting important limitations.
Transvaginal radiofrequency ablation continues to build evidence for uterine fibroids
A 2026 multicentre prospective study evaluates the efficacy, safety and reproducibility of this minimally invasive technique.
A nectin-4 antibody-drug conjugate shows early signals in cervical cancer
Early data presented at ESMO 2026 suggest activity of bulumtatug fuvedotin in advanced or metastatic disease.
ESHRE proposes international limits on offspring per gamete donor
The European society proposes a common framework to reduce uncertainty and protect people conceived through donation.
Vanillin in some vaping products draws attention over possible effects on embryonic development
A 2026 study reports that vanillin, a flavouring used in some liquids, can disrupt experimental embryonic stem-cell models.
Modern IVF strengthens the case for single-embryo transfer
Data presented at ESHRE 2026 point to strong cumulative outcomes with a single-embryo transfer strategy.
IVF: a 2026 review questions the value of many add-on treatments
A review of clinical trials concludes that many treatments added to IVF still lack clear evidence of benefit.
New rapid tests open a route to faster endometriosis diagnosis
In 2026, attention has turned to less invasive tests that could help reduce the long diagnostic delays associated with endometriosis.
4π radiotherapy planning aims to reduce haematological toxicity in cervical cancer
A 2026 study proposes combining non-coplanar planning and predictive models to reduce pelvic bone-marrow dose during radiotherapy.
Europe moves towards harmonised measures to protect gamete donors
In July 2026, the Council of Europe adopted a recommendation on harmonised measures to protect gamete donors, developed in collaboration with ESHRE.
Paracetamol during pregnancy: study explores possible associations with reproductive development
An observational study published in September 2026 found associations between prenatal paracetamol exposure and some reproductive measures in girls, but it does not establish causation.
Advanced hysteroscopy: new minimally invasive techniques for treating uterine lesions
New intrauterine tissue-removal techniques are expanding outpatient options for treating fibroids and polyps with less endometrial trauma.
ESHRE 2026: new evidence on IVF and fertility preservation
The July 2026 ESHRE Annual Meeting presented new data on single embryo transfer, oocyte freezing and access to fertility treatment.
AI-assisted uterine MRI: progress towards more quantitative reporting
New research presents Female-RHINO, an AI system designed to automate part of the quantitative analysis of uterine MRI.
Pre-eclampsia: new first-trimester predictive model improves early detection by 92%
A European multicentre study published in BJOG validates an algorithm combining biochemical and ultrasound markers to identify high-risk pregnancies with greater accuracy than current methods.
EMA approves new hormonal treatment for endometriosis with improved tolerability profile
The European Medicines Agency has approved a next-generation GnRH antagonist that reduces chronic pelvic pain without the side effects associated with conventional treatments.
Ovarian vitrification in Spain: SEF publishes results of the first 500 cases
The SEF National Activity Registry releases data on ovarian tissue cryopreservation, showing ovarian function restoration rates above 60% in oncology patients.
SEGO 2025 caesarean section guideline: updated criteria to reduce rates in Spain
The new clinical guideline sets stricter criteria for elective caesarean section and promotes vaginal birth after caesarean (VBAC) as a safe option in adequately resourced centres.
Immunotherapy in ovarian cancer: ESGO publishes new first-line recommendations
The European Society of Gynaecological Oncology incorporates PARP inhibitors and anti-PD-L1 antibodies into the standard treatment scheme for advanced-stage epithelial ovarian carcinoma.
AI in obstetric ultrasound: European ECHO-AI project reaches 15 Spanish hospitals
A European consortium is training deep learning models for automatic detection of foetal abnormalities in the 20-week morphology scan, with promising initial results.
Hemodynamics-guided treatment could improve management of hypertension in pregnancy
A 2026 analysis suggests that tailoring treatment of hypertensive disorders in pregnancy to maternal hemodynamic profiles could reduce several complications.
Umbilical artery Doppler helps stratify risk in monochorionic twins
A 2026 study examines how an umbilical artery Doppler classification may help predict adverse outcomes in selective fetal growth restriction among monochorionic twin pregnancies.
Polycystic ovarian morphology and endometriosis can coexist
A 2026 cohort study examines the coexistence of polycystic ovarian morphology and endometriosis in a specialist gynecological ultrasound clinic.
MRI moves toward more precise classification of uterine fibroids
A 2026 retrospective analysis examines clinical trajectories and MRI-based triage of molecular uterine leiomyoma subtypes.
CIN2 classification may change how active surveillance is interpreted
A 2026 historical cohort examines the role of misclassification in apparent progression of cervical CIN2 lesions during active surveillance.
Preventing cesarean scar defects is gaining attention
A 2026 review focuses on long-term prevention of uterine scar defects after cesarean delivery, a problem that can be associated with symptoms and reproductive findings in some patients.
Primordial follicle density offers new clues for fertility preservation
A 2026 descriptive analysis examines primordial follicle density in human ovarian cortical tissue from post-pubertal females undergoing ovarian tissue cryopreservation.
Premature menopause is linked with higher hypertension risk
A 2026 publication reports an association between premature menopause and higher hypertension risk, highlighting cardiovascular health during the menopausal transition.
RSV vaccination during pregnancy shows real-world protection for infants
A systematic review and meta-analysis published in September 2026 evaluated whether maternal RSV vaccination protects infants from RSV-associated respiratory disease.
Menopausal hormone therapy is being reassessed through the lens of cardiovascular risk
A 2026 target-trial emulation evaluated menopausal hormone therapy and cardiovascular risk in perimenopausal and recently postmenopausal women with vasomotor symptoms.
Congress Calendar 2025–2026
Key scientific events in gynaecology and obstetrics across Spain and Europe.
64th SEGO National Congress
22–24 May 2025 · Congress Palace, Granada, Spain
Obstetrics, Gynaecology, Oncology, Reproduction
SpainEBCOG European Congress of Obstetrics & Gynaecology
11–14 June 2025 · Rome, Italy
Biennial congress of the European Board & College of O&G
EuropeESHRE Annual Meeting 2025
29 Jun – 2 Jul 2025 · Copenhagen, Denmark
Reproductive medicine and clinical embryology
EuropeESGO Congress 2025 – Gynaecological Oncology
5–8 September 2025 · Amsterdam, Netherlands
Gynaecological cancer: ovary, endometrium, cervix
EuropeISUOG World Congress 2025 – Ultrasound in O&G
12–15 October 2025 · Dubai, UAE
Ultrasound in obstetrics and gynaecology
InternationalSEF National Conference 2025
18–19 October 2025 · Madrid, Spain
Spanish Society of Fertility — IVF, cryopreservation
SpainFIGO World Congress of Gynecology & Obstetrics
15–19 November 2025 · Sydney, Australia
The world's largest biennial O&G congress
InternationalSESEGO Congress – Foetal Medicine & Prenatal Diagnosis
6–7 February 2026 · Barcelona, Spain
Prenatal diagnosis, foetal therapy, genetics
Spain